Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Toshiyoshi FujiwaraHarubumi Kato

Abstract

To determine the feasibility, safety, humoral immune response, and biologic activity of multiple intratumoral injections of Ad5CMV-p53, and to characterize the pharmacokinetics of Ad5CMV-p53 in patients with advanced non-small-cell lung cancer (NSCLC). Fifteen patients with histologically confirmed NSCLC and p53 mutations were enrolled onto this phase I trial. Nine patients received escalating dose levels of Ad5CMV-p53 (1 x 10(9) to 1 x 10(11) plaque-forming units) as monotherapy once every 4 weeks. Six patients were treated on a 28-day schedule with Ad5CMV-p53 in combination with intravenous administration of cisplatin (80 mg/m2). Patients were monitored for toxicity, vector distribution, antibody formation, and tumor response. Fifteen patients received a total of 63 intratumoral injections of Ad5CMV-p53 without dose-limiting toxicity. The most common treatment-related toxicity was a transient fever. Specific p53 transgene expression was detected using reverse-transcriptase polymerase chain reaction in biopsied tumor tissues throughout the period of treatment despite of the presence of neutralizing antiadenovirus antibody. Distribution studies revealed that the vector was detected in the gargle and plasma, but rarely in the ur...Continue Reading

References

Jul 5, 1991·Science·M HollsteinC C Harris
Oct 5, 1994·Journal of the National Cancer Institute·T FujiwaraJ A Roth
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M NishioT Takahashi
Nov 14, 1997·International Journal of Cancer. Journal International Du Cancer·N OgawaN Tanaka
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L ClaymanH Goepfert
Oct 28, 1998·Journal of the National Cancer Institute·T MitsudomiT Takahashi
May 18, 1999·Journal of the National Cancer Institute·S G SwisherM K Waugh
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NemunaitisJ Roth
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T WakuN Tanaka
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M SchulerC Rochlitz
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürgen KuballMartin Schuler
Jun 26, 2002·Cancer Gene Therapy·Richard E BullerMark Pegram
Jun 28, 2002·Cancer Cell·John D MinnaAdi F Gazdar
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven HirschfeldRichard Pazdur
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oday HamidAnthony F Shields
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lance C PagliaroColin P Dinney
Jul 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick F LangW K Alfred Yung

❮ Previous
Next ❯

Citations

Mar 2, 2011·Chinese Journal of Integrative Medicine·Dong Xue, Ping-Ping Li
Jan 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniel H StermanSteven M Albelda
Oct 3, 2006·Nature Medicine·Hiroyuki KishimotoToshiyoshi Fujiwara
Jun 10, 2006·Cell Death and Differentiation·K B SpurgersT J McDonnell
Dec 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunyoung KimYasufumi Kaneda
Feb 18, 2010·American Journal of Respiratory Cell and Molecular Biology·Anil VachaniSteven M Albelda
Dec 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yusuke EtoShinsaku Nakagawa
Jul 31, 2013·Drug Design, Development and Therapy·Wolfgang Hohenforst-SchmidtJohannes Brachmann
Jan 6, 2009·Uirusu·Toshiyoshi Fujiwara, Noriaki Tanaka
Apr 21, 2011·Expert Review of Anticancer Therapy·Toshiyoshi FujiwaraShunsuke Kagawa
Oct 11, 2013·Expert Opinion on Biological Therapy·Hiroshi TazawaToshiyoshi Fujiwara
Feb 17, 2009·Expert Opinion on Biological Therapy·Toshiyoshi Fujiwara
Jan 12, 2011·Expert Opinion on Biological Therapy·Hiroshi TazawaToshiyoshi Fujiwara
Jul 22, 2006·Expert Opinion on Biological Therapy·Dmitry I Gabrilovich
Nov 8, 2011·Clinics in Chest Medicine·Anil VachaniSteven M Albelda
Nov 10, 2009·Seminars in Cancer Biology·Michael P DickensPeter M Fischer
Apr 21, 2009·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Songtao ZhangHongwei Zhao
Jan 24, 2007·Thoracic Surgery Clinics·Eric M Toloza
Nov 30, 2006·The Annals of Thoracic Surgery·Rebecca P Petersen, Thomas A D'Amico
Feb 24, 2010·Cancer Science·Hiroshi KawahiraHideaki Shimada
Jan 17, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yasumoto YamasakiToshiyoshi Fujiwara
Dec 20, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Satoru KikuchiToshiyoshi Fujiwara
Dec 9, 2016·Human Gene Therapy·Dolan SondhiRonald G Crystal
Sep 21, 2007·The Journal of Gene Medicine·Ellen A M Schenk-BraatLeonie C M Kaptein
Nov 7, 2019·International Journal of Molecular Sciences·Mitsuhiro NakamuraHiroshi Fujiwara
Jun 20, 2020·European Respiratory Review : an Official Journal of the European Respiratory Society·Andrew DeMaio, Daniel Sterman
Dec 3, 2016·Scientific Reports·Teppei OnishiToshiyoshi Fujiwara
Jul 28, 2019·Annals of Gastroenterological Surgery·Toshiyoshi Fujiwara
May 27, 2010·Molecular Cancer Therapeutics·Ryo SakaiToshiyoshi Fujiwara
Jun 22, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yasuhiro ShirakawaToshiyoshi Fujiwara

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.